Theranos wouldn’t have been public because it would have had to undergo much more scrutiny and if it did get to the public markets (not the pink sheets) smart i

Theranos wouldn’t have been public because it would have had to undergo much more scrutiny and if it did get to the public markets (not the pink sheets) smart investors would have shorted the hell out of it. The fundamental problem was that blood is too heterogeneous at the sample size they were drawing from for many (most?) of their tests. There’s lots of scientific literature out there. 60 minutes figuring out the right question to ask and then another 60 minutes googling would have been sufficient due diligence to pass on this investment. For the most part Theranos was not made up of sophisticated investors and any professional money that came in late should be fired.